MIRA Pharmaceuticals, Inc. Common Stock

MIRANASDAQ • USD
ThemeBiotech - Drug Development›Neuroscience & CNS
0.66 USD
↗ 0.01 (1.77%)AT CLOSE (03:59 PM EST)
0.65
↘ 0.01 (1.03%)
POST MARKET (AS OF 04:09 PM EST)
Post Market
AS OF 04:09 PM EST
0.65
↘ 0.01 (1.03%)
🔴Market: CLOSED

MIRA is currently priced at $0.66. Our models show a "Buy" technical signal alongside a "Neutral" fundamental rating. This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On valuation, MIRA trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Nov 13, 2026.

Open?$0.64
High?$0.66
Low?$0.61
Prev. Close?$0.65
Volume?92.5K
Avg. Volume?131.5K
VWAP?$0.63
Rel. Volume?0.70x
Bid / Ask
Bid?$0.63 × 1.3K
Ask?$0.65 × 10.3K
Spread?$0.02
Midpoint?$0.64
Valuation & Ratios
Market Cap?27.7M
Shares Out?42.0M
Float?29.2M
Float %?69.4%
P/E Ratio?N/A
P/B Ratio?3.40
EPS?-$0.74
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.
Themes
Biotech - Drug Development›Neuroscience & CNSCannabis›CBD & Hemp Products
Employees
2
Market Cap
27.2M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.mirapharmaceuticals.com
Listed
2023-08-03
Address
1200 BRICKELL AVENUE
MIAMI, FL 33131
Phone: 813-369-5150
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
50
Short Sent.?
100
Piotroski F-Score?0/9Weak
Altman Z-Score?397.88Safe
Confidence?43%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.97%Low
Short Interest?282.3K
Days to Cover?1.4
Free Float29.2M
Avg Daily Volume196.5K
Settlement Date2026-10-30
Financial Health
Current Ratio?200.08Strong
Quick Ratio?200.08Strong
Cash Ratio?88.42Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
50
3.40FAIR▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-2.6CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-380.2%WEAK▾
ROA?
S&P
3
-378.4%WEAK▾
Cash Flow & Enterprise
FCF?$-4638863
Enterprise Value?$24.1M
Fundamentals ratios updated end of day
MarketsMoversWatchlist